Shares of Zosano Pharma Corporation (NASDAQ:ZSAN) fell 14.3% on Monday . The company traded as low as $0.83 and last traded at $0.84. 981,837 shares were traded during trading, an increase of 14% from the average session volume of 859,986 shares. The stock had previously closed at $0.98.
Separately, ValuEngine upgraded Zosano Pharma Corporation from a “strong sell” rating to a “sell” rating in a report on Friday, September 1st.
The stock’s market capitalization is $32.95 million. The company’s 50 day moving average is $0.95 and its 200 day moving average is $0.95.
Zosano Pharma Corporation (NASDAQ:ZSAN) last issued its quarterly earnings data on Thursday, August 10th. The biotechnology company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.15) by ($0.02). During the same quarter in the previous year, the company earned ($0.54) EPS. Analysts anticipate that Zosano Pharma Corporation will post ($0.85) earnings per share for the current year.
Several large investors have recently modified their holdings of ZSAN. Victory Capital Management Inc. bought a new position in shares of Zosano Pharma Corporation during the first quarter valued at about $449,000. Perceptive Advisors LLC bought a new position in Zosano Pharma Corporation in the first quarter worth about $950,000. Nexthera Capital LP bought a new position in Zosano Pharma Corporation in the first quarter worth about $950,000. Endurant Capital Management LP bought a new position in Zosano Pharma Corporation in the first quarter worth about $1,135,000. Finally, Northern Trust Corp raised its stake in Zosano Pharma Corporation by 591.4% in the second quarter. Northern Trust Corp now owns 79,234 shares of the biotechnology company’s stock worth $112,000 after buying an additional 67,774 shares in the last quarter. 22.66% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: “Zosano Pharma Corporation (ZSAN) Trading Down 14.3%” was first published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this news story on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this news story can be viewed at https://www.chaffeybreeze.com/2017/09/25/zosano-pharma-corporation-zsan-trading-down-14-3.html.
About Zosano Pharma Corporation
Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability.
Receive News & Ratings for Zosano Pharma Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zosano Pharma Corporation and related companies with MarketBeat.com's FREE daily email newsletter.